REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Armour Share Purchase Agreement

15 Jun 2020 07:56

RNS Number : 9408P
Oilex Ltd
15 June 2020
 

ASX - RNS Announcement

 

15 June 2020

 

ASX: OEX

AIM: OEX

 

 

Re: Armour Share Purchase Agreement

 

Oilex Limited (Oilex or the Company) is pleased to announce it has entered into a conditional binding Share Purchase Agreement (SPA) with Armour Energy Limited (Armour: ASX:AJQ) for the proposed sale of all of its interests in the Cooper-Eromanga Basin (Proposed Transaction).

 

Pursuant to the SPA, Armour will acquire 100% of the issued capital of CoEra Limited (CoEra), a wholly owned Company subsidiary which holds all of Oilex's interests in the Cooper-Eromanga Basin.

 

Background

 

On 27 May 2020, the Company announced it had entered into a binding Heads of Agreement with Armour to sell all of its interests in the Cooper-Eromanga Basin including a:

79.33% direct interest in two Petroleum Exploration Licences (PEL 112 and PEL 444) with an option to acquire the remaining 20.67%; and

right to acquire 27 Petroleum Retention Licences from Senex Limited (Northern Fairway PRLs).

 

As consideration for the Proposed Transaction, at completion Armour will issue up to 34.5 million Armour shares to Oilex (or its nominees) as follows:

Tranche 1

24,500,000 fully paid ordinary shares in Armour upon completion of the Proposed Transaction (Consideration Shares); and

Tranche 2

If, at any time within 90 days from completion, the closing volume weighted average price of Consideration Shares trading on the ASX falls below $0.037 then Armour shall be required to issue such additional shares in itself to the Company, or its nominee, to ensure the Company receives a consideration value of A$906,500 (Adjustment Shares). Any such Adjustment Shares issued shall:

not exceed an amount of ten (10) million Armour shares;

be subject to any required shareholder or regulatory approval.

 

The Consideration Shares issued will be subject to a twelve (12) month voluntary escrow from completion. Any Adjustment Shares issued will be held on escrow for a period of nine (9) months from the date of issue.

 

In addition, at the completion of the Proposed Transaction, Armour will pay reimburse Oilex A$125,000 for past costs incurred.

 

The Company will nominate Orthogonal Enterprises Pty Ltd to receive up to 3.45 million shares (10%) of the Consideration Shares as payment for services rendered in assisting the Company to build its Cooper-Eromanga portfolio.

 

Conditions Precedent

 

Pursuant to the SPA, completion is subject to the satisfaction of various conditions precedent on or before 15 September 2020 including the successful:

assignment of the option to acquire the remaining 20.67% interest in PEL 112 and PEL 444;

novation of the agreement with Senex Energy Limited including the execution of various deeds of assignment of assumption to enable Armour to acquire the Northern Fairway PRLs; and

receipt of Armour shareholder approval to issue the Consideration Shares.

 

CoEra and each of its subsidiaries were incorporated by Oilex after 30 June 2019. Accordingly, there was no revenue or earnings attributable to Oilex for the year ended 30 June 2019. As at 31 December 2019, the Cooper-Eromanga Basin assets being disposed of by Oilex had an unaudited carrying value of A$331,000.

Assuming completion of the Proposed Transaction, Oilex will no longer have any oil and gas asset interests in Australia and will be focused on further developing its asset base in India and the UK Continental Shelf (UKCS).

 

Managing Director and incoming Executive Chairman of Oilex, Joe Salomon, said;

 

"The Company is pleased this transaction has progressed quickly, with a definitive agreement now executed. We will continue to work closely with Armour in coming weeks to finalise the sale of our Cooper-Eromanga assets."

 

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Executive Chairman

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230

UK

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUVVNRROUNARR
Date   Source Headline
14th May 20217:00 amRNSIssue of Securities and Appendix 2A
7th May 20217:00 amRNSNotice of General Meeting
6th May 20212:00 pmRNSPrice Monitoring Extension
6th May 20219:55 amRNSChange of Interests of Substantial Holder
30th Apr 20217:36 amRNSMarch 2021 Quarterly Report
29th Apr 202111:06 amRNSIssue of Securities
23rd Apr 202110:24 amRNSIssue of Securities
23rd Apr 20217:00 amRNSInd Govt approval of Cambay PSC Work Prog/Budget
21st Apr 20211:43 pmRNSAcquisition Funding Arranged
13th Apr 20217:00 amRNSBhandut PSC PI Sale Finalisation
7th Apr 20215:51 pmRNSIssue of Securities
6th Apr 202111:00 amRNSPrice Monitoring Extension
6th Apr 20219:05 amRNSSecond Price Monitoring Extn
6th Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20219:32 amRNSUpdate Regarding Cambay Settlement
17th Mar 20217:00 amRNSAppendix 2A
16th Mar 20217:00 amRNSCorrection: Equity Issue
15th Mar 20217:19 amRNSHalf Year Accounts
15th Mar 20217:00 amRNSSeries D Loan Restructure and Equity Issue
17th Feb 20217:00 amRNSAppendix 3Y P Haywood
17th Feb 20217:00 amRNSAppendix 3Y P Schwarz
15th Feb 20217:59 amRNSUpdate on proposal to acq interest in Cambay PSC
15th Feb 20217:46 amRNSTrading Halt Request
12th Feb 20218:15 amRNSIssue of Securities and Appendix 2A
1st Feb 20217:00 amRNSDecember 2020 Quarterly Report
24th Dec 20207:00 amRNSSeries C Loan Extension
17th Dec 202011:20 amRNSExecutive Directors Contract Extensions
17th Dec 202010:51 amRNSIssue of Securities
16th Dec 20207:00 amRNSResults of Annual General Meeting
14th Dec 20207:00 amRNSCompletion of East Irish Sea Transaction P2446
16th Nov 20207:00 amRNS2020 Notice of Annual General Meeting
6th Nov 20207:55 amRNSCorrection Waiver Granted
5th Nov 20207:30 amRNSWaiver Granted
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Financial Report
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Business Review
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Announcement
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Chairmans Review
2nd Nov 20207:00 amRNSAudited 2020 Annual Report - Directors Report
30th Oct 20209:54 amRNSSeptember 2020 Quarterly Report
30th Oct 20209:37 amRNSSeries C Loan Restructure
15th Oct 20208:54 amRNSArmour Completion and Update on Projects
1st Oct 20207:08 amRNSAppendix 4G
1st Oct 20207:00 amRNSCorporate Governance Statement 2020
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Directors Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Business Review
1st Oct 20207:00 amRNSUnaudited Annual Report 2020 - Announcement
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report - Financial Report
1st Oct 20207:00 amRNSUnaudited 2020 Annual Report -Chairmans Review
14th Sep 202012:17 pmRNSArmour Share Purchase Agreement – Update
10th Aug 20207:00 amRNSIssue of Securities and Appendix 2A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.